MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Dynamic prediction of motor diagnosis in Huntington’s disease using a joint modeling approach

    K. Li, E. Furr Stimming, S. Luo, K. Li (Houston, TX, USA)

    Objective: Compare various clinical and biomarker trajectories for tracking Huntington's disease (HD) progression and predicting motor conversion. Background: Huntington’s disease (HD) is a fatal neurodegenerative disease…
  • 2017 International Congress

    Demographic and Clinical Characteristics and Tetrabenazine (TBZ) Persistence in Patients With Huntington Disease (HD)-Associated Chorea

    V. Sung, R. Iyer, S. Gandhi, V. Abler, B. Davis, D. Irwin, K. Anderson (Birmingham, AL, USA)

    Objective: To characterize demographic and clinical characteristics of HD patients with chorea based on TBZ use status, and to examine treatment persistence with TBZ in…
  • 2017 International Congress

    Efficacy, Safety, and Tolerability of Pridopidine in Huntington Disease (HD): Results From the Phase II Dose-Ranging Study, Pride-HD

    R. Reilmann, A. McGarry, G. Landwehrmeyer, K. Kieburtz, I. Grachev, E. Eyal, J. Savola, B. Borowsky, S. Papapetropoulos, M. Hayden (Münster, Germany)

    Objective: To assess efficacy, safety, and tolerability of multiple doses of pridopidine in HD patients (pts) with signs of motor dysfunction. Background: Prior trials suggested…
  • 2017 International Congress

    Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.

    L. Mendoza Vega, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. De-la-Cruz-Landero, N. Davila-Avila, K. Salinas-Barboza, S. Isais-Millan (Mexico City, Mexico)

    Objective: To describe the clinical features and CAG repeats in a large population of Mexican patients with Huntington's disease and its relation to the age…
  • 2017 International Congress

    Prescription pattern of treatment in Mexican patients with Huntington’s Disease.

    A. De-la-Cruz, L. Mendoza Vega, N. Davila Avila, K. Salinas Barboza, S. Isais Millan, A. Cervantes Arriaga, M. Rodriguez Violante (Ciudad de Mexico, Mexico)

    Objective: To describe the prescription pattern for the treatment of HD in a sample of Mexican patients from a tertiary referral center. Background: Huntington’s disease…
  • 2017 International Congress

    Prevalence of substance abuse in Huntington´s disease patients and its relationship with neuropsychiatric symptoms

    K. SALINAS BARBOZA, L. MENDOZA VEGA, A. CRUZ LANDERO, S. ISAIS MILLAN, M. RODRIGUEZ VIOLANTE, A. CERVANTES ARRIAGA, N. DAVILA AVILA (MEXICO, Mexico)

    Objective: To describe the prevalence of substance abuse and its relationship with neuropsychiatric features in Huntington’s disease (HD). Background: Substance abuse is not well established…
  • 2017 International Congress

    Baseline multimodal information predicts future motor impairment in premanifest Huntington’s disease

    E. Castro, P. Polosecki, I. Rish, G. Cecchi (Yorktown Heights, NY, USA)

    Objective: To evaluate the prognostic accuracy of structural magnetic resonance imaging and genetic-based measures in premanifest Huntington’s disease for estimating future motor impairment. Background: Despite…
  • 2017 International Congress

    Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

    Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians   Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…
  • 2017 International Congress

    Factors Influencing Completion of Predictive Testing for Huntington’s Disease (HD)

    M. Patel, V. Sung (Birmingham, AL, USA)

    Objective: To determine if the new simplified testing protocol led to an increase in completion rate of predictive testing for HD, and to study some…
  • 2017 International Congress

    Sensory modulation of postural control in Huntington’s disease

    F. Porciuncula, K. Marder, P. Wasserman, A. Rao (New York, NY, USA)

    Objective: To characterize sensory modulation of postural control in Huntington's disease (HD); and to identify postural metrics that are sensitive in the prodromal stage of…
  • « Previous Page
  • 1
  • …
  • 1628
  • 1629
  • 1630
  • 1631
  • 1632
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley